Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
about
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy and safety profile of ...... d PegBase observational study.
@en
type
label
Efficacy and safety profile of ...... d PegBase observational study.
@en
prefLabel
Efficacy and safety profile of ...... d PegBase observational study.
@en
P2093
P2860
P356
P1476
Efficacy and safety profile of ...... ld PegBase observational study
@en
P2093
Alessandra Mangia
Christoph P Berg
Elisa Negri
François Habersetzer
Graham R Foster
Manuela Curescu
Marco Castillo
PegBase Group Investigators
Silke Ahlers
Spilios Manolakopoulos
P2860
P304
P356
10.20524/AOG.2017.0136
P577
2017-03-23T00:00:00Z